The treatment of inverse psoriasis with the traditional use of topical steroids may be associated with a greater risk of unwanted side effects, including striae, atrophy, and telangiectasia. The National Psoriasis Foundation consensus statement provides a practical treatment algorithm that should be used when treating these patients. We present a case report highlighting use of these guidelines.
KalbR.E., BagelJ., KormanN.J.Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis FoundationJ Am Acad Dermatol.2009; 60(1): 120–4.
2.
FitzpatrickT.B.Dermatology in general medicine. 4th ed. New York: McGraw-Hill, Health Professions Division; 1993.
3.
VigliogliaP., JonesM.L., PeetsE.A.Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses. J Intern Med Res1990; 18(6): 460–7.
4.
LebwohlM., PeetsE., ChenV.Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy. Int J Dermatol.1993; 32(11): 830–1.
5.
LebwohlM.G., TanM.H., MeadorS.L., SingerG.Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol.2001; 44(1): 77–82.
6.
GribetzC., LingM., LebwohlM.Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol.2004; 51(5): 731–8.
7.
KreuterA., SommerA., HyunJ.1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. Arch Dermatol2006; 142(9): 1138–43.
8.
LebwohlM., FreemanA.K., ChapmanM.S., FeldmanS.R., HartleJ.E., HenningA.Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol.2004; 51(5): 723–30.
9.
LebwohlM., FreemanA., ChapmanM.S., FeldmanS., HartleJ., HenningA.Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol.2005; 141(9): 1154.
10.
FreemanA.K., LinowskiG.J., BradyC.Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol.2003; 48(4): 564–8.
11.
EzquerraG., ReganaM., AcostaE., MilletP.Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol.2006; 5(4): 334–6.
12.
KienbaumS., LehmannP., RuzickaT.Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol.1996; 135(4): 647–50.
13.
ZanchiM., FavotF., BizzariniM., PiaiM., DoniniM., SedonaP.Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol.2008; 22(4): 431–6.
14.
MafongE.A., FriedmanP.M., KauvarA.N., BernsteinL.J., Alexiades-ArmenakasM., GeronemusR.G.Treatment of inverse psoriasis with the 308 nm excimer laser. Dermatol Surg.2002; 28(6): 530–2.
15.
CarrascosaJ.M., SoriaX., DomingoH., FerrandizC.Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment. Dermatol Surg.2007; 33(3): 361–3.
